EUVIMEDEUVIMED entdecken
Crossref

Qingre Huayu Jianpi prescription alleviates the inflammatory transformation of colitis-associated colorectal cancer by inhibiting the IL-17RA/ACT1/NF-κB axis

Yilin Duan, Yao Lu, Zhenglin Liu, Jin Zhang, Zhiyu Yang, Yihan Guo, Yi Yang, Wenjia Lin, Yuxing Shuai, Jiaying Huang, Yingjian Xu, Renxiong Wu und 3 weitere

Journal of Ethnopharmacology · 2025

DOI: 10.1016/j.jep.2025.119554 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Ethnopharmacology, 2025. Verfasst von Yilin Duan und 14 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Colitis-Associated Neoplasms, Receptors, Interleukin-17, Colitis, Ulcerative. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Natural Science Foundation of Guangdong Province, National Natural Science Foundation of China, Innovative Research Group Project of the National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ETHNOPHARMACOLOGICAL RELEVANCE: Inflammation-to-cancer transformation is critical for the progression of ulcerative colitis to colitis-associated colorectal cancer (CAC). AIM OF THE STUDY: To explore the role and potential mechanisms of Qingre Huayu Jianpi prescription (QHJ) treatment in the development of CAC. MATERIALS AND METHODS: Combined network pharmacology and transcriptome analyses were used to investigate QHJ-associated targets and pathways in the context of CAC. Using clinical data and a murine CAC model, we examined QHJ effects on pathological morphology, inflammatory factors, and key target pathways. RESULTS: Network pharmacology analysis identified the interleukin 17 receptor A (IL-17RA)/ACT1/nuclear factor kappa B (NF-κB) axis as critical in the inflammation-to-CAC transformation and for QHJ effects in CAC. Western blot and multiplex immunofluorescence analyses revealed significant upregulation of the IL-17RA/ACT1/NF-κB axis along with matrix metalloproteinase (MMP)7, MMP9, and chemokine ligand 2 (CCL2) in human tumor tissues. QHJ significantly ameliorated CAC-related symptoms in mice in vivo by downregulating the IL-17RA/ACT1/NF-κB axis. This reduced the number of colorectal adenomas, increased colorectal length, and improved the structure of colonic mucosal glands. Additionally, QHJ inhibited the expression of pro-inflammatory factors and decreased the levels of MMP7, MMP9, and CCL2, ultimately suppressing the inflammation-to-cancer transformation. CONCLUSION: QHJ exhibited significant therapeutic effects on CAC in mice, likely due to its inhibitory action on the IL-17RA/ACT1/NF-κB axis. This study lays the foundation for research into the pathogenesis of CAC and the clinical application of QHJ.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drugs, Chinese HerbalColitis-Associated NeoplasmsReceptors, Interleukin-17Colitis, UlcerativeColorectal NeoplasmsAnti-Inflammatory AgentsAnimalsNF-kappa BHumansMiceMaleMice, Inbred C57BLSignal TransductionColitisFemaleInflammationDisease Models, Animal

Stichwörter der Autor:innen

Colitis-associated colorectal cancerIL-17RA/ACT1/NF-κB signaling axisInflammation-to-cancer transformationNetwork pharmacologyTraditional Chinese medicineTranscriptomics

Substanzen

NF-kappa BDrugs, Chinese HerbalReceptors, Interleukin-17Anti-Inflammatory Agents

Autor:innen und Institutionen

  • School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.
  • First Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.
  • Gaozhou Hospital of Traditional Chinese Medicine Affiliated to Guangzhou University of Chinese Medicine, Gaozhou, 525200, China.
  • Gaozhou Hospital of Traditional Chinese Medicine Affiliated to Guangzhou University of Chinese Medicine, Gaozhou, 525200, China. Electronic address: wyq6575@163.com.
  • Guangzhou University of Chinese Medicine Science and Technology Innovation Center, Guangzhou, 510405, China. Electronic address: liyanwu@gzucm.edu.cn.
  • Gaozhou Hospital of Traditional Chinese Medicine Affiliated to Guangzhou University of Chinese Medicine, Gaozhou, 525200, China. Electronic address: junyuke21@163.com.

Förderung

  • Natural Science Foundation of Guangdong Province
  • National Natural Science Foundation of China
  • Innovative Research Group Project of the National Natural Science Foundation of China

Zitieren

APA

Duan, Y., Lu, Y., Liu, Z., Zhang, J., Yang, Z., Guo, Y., Yang, Y., Lin, W., Shuai, Y., Huang, J., Xu, Y., Wu, R., Wu, Y., Li, Y., & Ke, J. (2025). Qingre Huayu Jianpi prescription alleviates the inflammatory transformation of colitis-associated colorectal cancer by inhibiting the IL-17RA/ACT1/NF-κB axis. Journal of Ethnopharmacology. https://doi.org/10.1016/j.jep.2025.119554

Vancouver

Duan Y, Lu Y, Liu Z, Zhang J, Yang Z, Guo Y, et al. Qingre Huayu Jianpi prescription alleviates the inflammatory transformation of colitis-associated colorectal cancer by inhibiting the IL-17RA/ACT1/NF-κB axis. Journal of Ethnopharmacology. 2025. doi:10.1016/j.jep.2025.119554

BibTeX
@article{Duan2025,
  author = {Duan, Yilin and Lu, Yao and Liu, Zhenglin and Zhang, Jin and Yang, Zhiyu and Guo, Yihan and Yang, Yi and Lin, Wenjia and Shuai, Yuxing and Huang, Jiaying and Xu, Yingjian and Wu, Renxiong and Wu, Yongqiang and Li, Yanwu and Ke, Junyu},
  title = {Qingre Huayu Jianpi prescription alleviates the inflammatory transformation of colitis-associated colorectal cancer by inhibiting the IL-17RA/ACT1/NF-κB axis},
  journal = {Journal of Ethnopharmacology},
  year = {2025},
  doi = {10.1016/j.jep.2025.119554}
}
Kostenlos starten →